OSIRIS THERAPEUTICS INC NEW's ticker is OSIR and the CUSIP is 68827R108. A total of 63 filers reported holding OSIRIS THERAPEUTICS INC NEW in Q1 2014. The put-call ratio across all filers is 2.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $78,000 | -7.1% | 16,300 | -4.7% | 0.00% | – |
| Q4 2016 | $84,000 | -5.6% | 17,100 | -4.5% | 0.00% | – |
| Q3 2016 | $89,000 | -9.2% | 17,900 | -7.3% | 0.00% | – |
| Q2 2016 | $98,000 | -14.0% | 19,300 | -3.5% | 0.00% | – |
| Q1 2016 | $114,000 | -48.4% | 20,000 | -6.1% | 0.00% | – |
| Q4 2015 | $221,000 | -43.8% | 21,300 | 0.0% | 0.00% | -100.0% |
| Q3 2015 | $393,000 | -5.1% | 21,300 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $414,000 | +15.0% | 21,300 | 0.0% | 0.00% | – |
| Q1 2015 | $360,000 | 0.0% | 21,300 | 0.0% | 0.00% | – |
| Q4 2014 | $360,000 | +34.3% | 21,300 | 0.0% | 0.00% | – |
| Q3 2014 | $268,000 | -19.5% | 21,300 | 0.0% | 0.00% | – |
| Q2 2014 | $333,000 | +9.2% | 21,300 | 0.0% | 0.00% | – |
| Q1 2014 | $305,000 | -12.1% | 21,300 | 0.0% | 0.00% | – |
| Q4 2013 | $347,000 | -6.0% | 21,300 | -4.0% | 0.00% | -100.0% |
| Q3 2013 | $369,000 | +85.4% | 22,190 | +12.1% | 0.00% | – |
| Q2 2013 | $199,000 | – | 19,790 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venator Capital Management Ltd. | 218,300 | $4,248,000 | 3.89% |
| Consonance Capital Management LP | 1,176,195 | $22,889,000 | 2.30% |
| RATIONAL ADVISORS LLC | 64,000 | $1,245,000 | 0.40% |
| PRINCETON CAPITAL MANAGEMENT INC | 34,825 | $678,000 | 0.36% |
| TURNER INVESTMENTS LLC | 91,500 | $1,780,000 | 0.33% |
| FALCON POINT CAPITAL, LLC | 26,596 | $518,000 | 0.18% |
| Freedom Investment Management, Inc. | 76,469 | $1,488,000 | 0.15% |
| Baker Brothers Advisors | 499,193 | $9,714,000 | 0.08% |
| Spark Investment Management LLC | 27,600 | $536,000 | 0.08% |
| OXFORD ASSET MANAGEMENT LLP | 128,247 | $2,496,000 | 0.07% |